Literature DB >> 18573533

Moderate perinatal arsenic exposure alters neuroendocrine markers associated with depression and increases depressive-like behaviors in adult mouse offspring.

Ebany J Martinez1, Bethany L Kolb, Angela Bell, Daniel D Savage, Andrea M Allan.   

Abstract

Arsenic is one of the most common heavy metal contaminants found in the environment, particularly in water. We examined the impact of perinatal exposure to relatively low levels of arsenic (50 parts per billion, ppb) on neuroendocrine markers associated with depression and depressive-like behaviors in affected adult C57BL/6J mouse offspring. Whereas most biomedical research on arsenic has focused on its carcinogenic potential, a few studies suggest that arsenic can adversely affect brain development and neural function. Compared to controls, offspring exposed to 50 parts per billion arsenic during the perinatal period had significantly elevated serum corticosterone levels, reduced whole hippocampal CRFR 1 protein level and elevated dorsal hippocampal serotonin 5HT 1A receptor binding and receptor-effector coupling. 5HT 1A receptor binding and receptor-effector coupling were not different in the ventral hippocampal formation, entorhinal or parietal cortices, or inferior colliculus. Perinatal arsenic exposure also significantly increased learned helplessness and measures of immobility in a forced swim task. Taken together, these results suggest that perinatal arsenic exposure may disrupt the regulatory interactions between the hypothalamic-pituitary-adrenal axis and the serotonergic system in the dorsal hippocampal formation in a manner that predisposes affected offspring to depressive-like behavior. These results are the first to demonstrate that relatively low levels of arsenic exposure during development can have long-lasting adverse effects on behavior and neurobiological markers associated with these behavioral changes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18573533      PMCID: PMC2585488          DOI: 10.1016/j.neuro.2008.05.004

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  55 in total

1.  Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system.

Authors:  C A Lowry; J E Rodda; S L Lightman; C D Ingram
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  Effect of corticotropin releasing factor receptor 1 antagonist on extracellular norepinephrine, dopamine and serotonin in hippocampus and prefrontal cortex of rats in vivo.

Authors:  K Isogawa; J Akiyoshi; T Hikichi; Y Yamamoto; T Tsutsumi; H Nagayama
Journal:  Neuropeptides       Date:  2000 Jun-Aug       Impact factor: 3.286

3.  Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus.

Authors:  L G Kirby; K C Rice; R J Valentino
Journal:  Neuropsychopharmacology       Date:  2000-02       Impact factor: 7.853

Review 4.  Glucocorticoid receptor function in vitro in patients with major depression.

Authors:  Carmine M Pariante
Journal:  Stress       Date:  2004-12       Impact factor: 3.493

Review 5.  Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.

Authors:  K T Kitchin
Journal:  Toxicol Appl Pharmacol       Date:  2001-05-01       Impact factor: 4.219

6.  Ontogeny of 5-HT1A receptor expression in the developing hippocampus.

Authors:  Tushar D Patel; Feng C Zhou
Journal:  Brain Res Dev Brain Res       Date:  2005-06-09

Review 7.  The HPA and immune axes in stress: the involvement of the serotonergic system.

Authors:  B E Leonard
Journal:  Eur Psychiatry       Date:  2005-10       Impact factor: 5.361

8.  Effects of arsenite on central monoamines and plasmatic levels of adrenocorticotropic hormone (ACTH) in mice.

Authors:  J M Delgado; L Dufour; J I Grimaldo; L Carrizales; V M Rodríguez; M E Jiménez-Capdeville
Journal:  Toxicol Lett       Date:  2000-09-30       Impact factor: 4.372

9.  The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings.

Authors:  Alessandro Serretti; Paola Artioli; Cristina Lorenzi; Adele Pirovano; Viviana Tubazio; Raffaella Zanardi
Journal:  Int J Neuropsychopharmacol       Date:  2004-09-30       Impact factor: 5.176

10.  Arsenic alters the function of the glucocorticoid receptor as a transcription factor.

Authors:  R C Kaltreider; A M Davis; J P Lariviere; J W Hamilton
Journal:  Environ Health Perspect       Date:  2001-03       Impact factor: 9.031

View more
  26 in total

1.  Arsenic exposure during embryonic development alters the expression of the long noncoding RNA growth arrest specific-5 (Gas5) in a sex-dependent manner.

Authors:  Kevin K Caldwell; Alexander Hafez; Elizabeth Solomon; Matthew Cunningham; Andrea M Allan
Journal:  Neurotoxicol Teratol       Date:  2017-11-11       Impact factor: 3.763

2.  Effects of prenatal exposure to sodium arsenite on motor and food-motivated behaviors from birth to adulthood in C57BL6/J mice.

Authors:  Vincent P Markowski; Elizabeth A Reeve; Kristen Onos; Mina Assadollahzadeh; Naomi McKay
Journal:  Neurotoxicol Teratol       Date:  2012-01-15       Impact factor: 3.763

3.  Fluoxetine treatment ameliorates depression induced by perinatal arsenic exposure via a neurogenic mechanism.

Authors:  Christina R Tyler; Benjamin R Solomon; Adam L Ulibarri; Andrea M Allan
Journal:  Neurotoxicology       Date:  2014-06-18       Impact factor: 4.294

4.  Protective effect of gallic acid against arsenic-induced anxiety-/depression- like behaviors and memory impairment in male rats.

Authors:  Noreen Samad; Sadia Jabeen; Imran Imran; Iqra Zulfiqar; Kainat Bilal
Journal:  Metab Brain Dis       Date:  2019-05-22       Impact factor: 3.584

5.  Cortical Astrocytes Acutely Exposed to the Monomethylarsonous Acid (MMAIII) Show Increased Pro-inflammatory Cytokines Gene Expression that is Consistent with APP and BACE-1: Over-expression.

Authors:  C Escudero-Lourdes; E E Uresti-Rivera; C Oliva-González; M A Torres-Ramos; P Aguirre-Bañuelos; A J Gandolfi
Journal:  Neurochem Res       Date:  2016-06-20       Impact factor: 3.996

6.  Soil arsenic surveys of New Orleans: localized hazards in children's play areas.

Authors:  Howard W Mielke; Chris R Gonzales; Elise Cahn; Jessica Brumfield; Eric T Powell; Paul W Mielke
Journal:  Environ Geochem Health       Date:  2010-02-09       Impact factor: 4.609

7.  Prenatal arsenic exposure alters the programming of the glucocorticoid signaling system during embryonic development.

Authors:  Katharine E Caldwell; Matthew T Labrecque; Benjamin R Solomon; Abdulmehdi Ali; Andrea M Allan
Journal:  Neurotoxicol Teratol       Date:  2014-11-21       Impact factor: 3.763

8.  Perinatal exposure to 50 ppb sodium arsenate induces hypothalamic-pituitary-adrenal axis dysregulation in male C57BL/6 mice.

Authors:  Samantha L Goggin; Matthew T Labrecque; Andrea M Allan
Journal:  Neurotoxicology       Date:  2012-08-31       Impact factor: 4.294

9.  Learning deficits in C57BL/6J mice following perinatal arsenic exposure: consequence of lower corticosterone receptor levels?

Authors:  Ebany J Martinez-Finley; Abdul-Mehdi S Ali; Andrea M Allan
Journal:  Pharmacol Biochem Behav       Date:  2009-09-13       Impact factor: 3.533

Review 10.  A systematic review of arsenic exposure and its social and mental health effects with special reference to Bangladesh.

Authors:  Johanna Brinkel; Mobarak H Khan; Alexander Kraemer
Journal:  Int J Environ Res Public Health       Date:  2009-05-08       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.